Risk of candidiasis associated with interleukin-17 inhibitors: implications and management-Reference-Cited by-同舟云学术

Risk of candidiasis associated with interleukin-17 inhibitors: implications and management

Published:2023-10-20 Issue: Volume: Page:1-15
ISSN:2150-1203
Container-title:Mycology
language:en
Short-container-title:Mycology

Author:

Bilal Hazrat¹,Khan Muhammad Nadeem²,Khan Sabir¹,Fang Wenjie³,Chang Wenqiang⁴,Yin Bin⁵,Song Ning-Jing⁶,Liu Zhongrong⁷,Zhang Dongxing⁸⁹,Yao Fen¹⁰,Wang Xun¹,Wang Qian¹,Cai Lin¹,Hou Bing¹¹,Wang Jiayue¹²,Mao Chunyan¹²,Liu Lingxi¹²,Zeng Yuebin¹²

Affiliation:

1. Department of Dermatology, Second Affiliated Hospital of Shantou University Medical College, Shantou, China

2. Faculty of Biological Sciences, Department of Microbiology, Quaid-I-Azam University, Islamabad, Pakistan

3. Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai, China

4. School of Pharmacy, Shandong University, Qingdao, Shandong, China

5. Department of Dermatovenereology, Chengdu Second People’s Hospital, Chengdu, China

6. Department of Dermatology, Tongren Hospital, Shanghai Jiao Tong University, Shanghai, China

7. Department of Dermatology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

8. Department of Dermatology, Meizhou Dongshan Hospital, Meizhou, Guangdong, China

9. Department of Dermatology, Meizhou People’s Hospital, Meizhou, Guangdong, China

10. Department of Pharmacy, Shantou University School Medical College, Shantou, China

11. Department of Clinical Laboratory, Skin and Venereal Diseases Prevention and Control Hospital of Shantou City, Shantou, Guangdong, China

12. Department of Dermatology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21501203.2023.2265664

Reference106 articles.

1. Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

2. A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17

3. A Clinician’s Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis

5. “Candida AlbicansInteractions With The Host: Crossing The Intestinal Epithelial Barrier”

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies;Expert Opinion on Drug Safety;2024-09-12

2. The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer;Cancers;2024-08-28

3. Biologika als „game changer“;Deutsche Dermatologie;2024-07

4. Interleukin inhibitors and the associated risk of candidiasis;Frontiers in Immunology;2024-03-28